Investment Securities (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2012	Sep. 30, 2015	Sep. 28, 2015
Accounting Policies [Abstract]
Common shares reclassified	66,667
Stock issued as license fee, shares			8,000,000
Stock issued as license fee, value			$ 100,000
Common shares of Entest Biomedical, Inc		8,066,667